The goal of this research is to define biochemical mechanisms of avian retrovirus replication and the role of viral proteins in this process. These are multidisciplinary model studies that have direct application to development of anti-HIV agents. The first specific aim of this proposal is to understand the role of the matrix (MA) protein in viral replication. Experiments are proposed to further analyze the biological effect of point mutations in MA. Initial results suggest that the RSV MA has at least two additional biological functions in replication besides structural and transport roles. One of these, may be related to virus entry into the cell and/or uncoating of the virus particle. The other may be related to RNA packaging during assembly. Experiments are proposed to examine specific packaging of viral RNA by the RSV Gag protein in vitro and in vivo and directly evaluate a role for MA in this process. These studies are particularly important since they analyze the first phosphorylation site protein mutants in retroviral replication that alter growth in vivo. RNA mapping studies are also proposed to extend our knowledge of what constitute an RNA packaging signal for avian retroviruses. The second specific aim is to understand the mechanism of initiation of reverse transcription. These studies will continue to address the role of secondary structure in the U5 region of viral RNA in initiation of reverse transcription through the analysis of mutations in U5 RNA. Chemical and enzymatic mapping techniques will also be employed, both to confirm U5 structures already genetically defined and to probe the nature of initiation complexes formed with RT. Furthermore, efforts will be made to establish if there are sequence specific contacts between RT, U5 RNA, and primer in forming the initiation complex. In a separate line of investigation, we will characterize second site revertants which spontaneously arose from viruses containing deletions in RNA structures required for initiation of this process. We have also note that U5 sequences required for initiation of reverse transcription are homologous to known leader RNA packaging signal. We will therefore determine if US sequences contain overlapping functions for reverse transcription and RNA packaging.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA038046-14
Application #
2608016
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Cole, John S
Project Start
1984-07-01
Project End
1999-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
14
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Johnson, Michael; Morris, Shannon; Chen, Aiping et al. (2004) Selection of functional mutations in the U5-IR stem and loop regions of the Rous sarcoma virus genome. BMC Biol 2:8
Brin, Elena; Leis, Jonathan (2002) HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences. J Biol Chem 277:18357-64
Brin, Elena; Leis, Jonathan (2002) Changes in the mechanism of DNA integration in vitro induced by base substitutions in the HIV-1 U5 and U3 terminal sequences. J Biol Chem 277:10938-48
Morris, Shannon; Johnson, Michael; Stavnezer, Ed et al. (2002) Replication of avian sarcoma virus in vivo requires an interaction between the viral RNA and the TpsiC loop of the tRNA(Trp) primer. J Virol 76:7571-7
VerPlank, L; Bouamr, F; LaGrassa, T J et al. (2001) Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A 98:7724-9
Xiang, Y; Thorick, R; Vana, M L et al. (2001) Proper processing of avian sarcoma/leukosis virus capsid proteins is required for infectivity. J Virol 75:6016-21
Hindmarsh, P; Johnson, M; Reeves, R et al. (2001) Base-pair substitutions in avian sarcoma virus U5 and U3 long terminal repeat sequences alter the process of DNA integration in vitro. J Virol 75:1132-41
Brin, E; Yi, J; Skalka, A M et al. (2000) Modeling the late steps in HIV-1 retroviral integrase-catalyzed DNA integration. J Biol Chem 275:39287-95
Hindmarsh, P; Ridky, T; Reeves, R et al. (1999) HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol 73:2994-3003
Morris, S; Leis, J (1999) Changes in Rous sarcoma virus RNA secondary structure near the primer binding site upon tRNATrp primer annealing. J Virol 73:6307-18

Showing the most recent 10 out of 43 publications